Skip to main content
logo
Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.5300
+0.0244 (4.83%)
At close: Feb 17, 2026, 4:00 PM EST
0.5474
+0.0174 (3.28%)
Pre-market: Feb 18, 2026, 4:29 AM EST

Vistagen Therapeutics Revenue

Vistagen Therapeutics had revenue of $303.00K in the quarter ending December 31, 2025, with 29.49% growth. This brings the company's revenue in the last twelve months to $790.00K, up 13.18% year-over-year. In the fiscal year ending March 31, 2025, Vistagen Therapeutics had annual revenue of $486.00K, down -54.32%.

Revenue (ttm)
$790.00K
Revenue Growth
+13.18%
P/S Ratio
23.77
Revenue / Employee
$13,373
Employees
59
Market Cap
21.00M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025486.00K-578.00K-54.32%
Mar 31, 20241.06M1.29M-
Mar 31, 2023-227.00K-1.34M-
Mar 31, 20221.11M19.40K1.78%
Mar 31, 20211.09M--
Mar 31, 2020---
Mar 31, 2019---
Mar 31, 2018---
Mar 31, 20171.25M--
Mar 31, 2016---
Mar 31, 2015---
Mar 31, 2014---
Mar 31, 2013200.40K-1.14M-85.07%
Mar 31, 20121.34M-728.80K-35.19%
Mar 31, 20112.07M--
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

VTGN News

More News